Navigation Links
Clarient Generates 52% Revenue Increase in Third Quarter 2007
Date:10/30/2007

ared to the third quarter of 2006.

Gross profit in the third quarter of 2007 was $6.3 million, an increase of 79 percent as compared to $3.5 million in the third quarter of 2006. Gross margin in the third quarter 2007 was 52 percent, as compared to 45 percent in the 2006 third quarter. Andrews noted that gross margins are improving as a result of volume growth and better use of the Company's capacity, a better revenue mix, process efficiencies and improved pricing with vendors.

Total operating expenses were $8.7 million for the third quarter of 2007, an increase of 37 percent compared to $6.4 in the third quarter of 2006. The growth in expense was primarily due to restructuring charges incurred during the quarter relating to changes in management, increased professional fees and increased selling, bad debt and collection expenses due to the Company's revenue growth.

Operating loss was $2.4 million, compared to a loss of $2.8 million in the third quarter 2006, a reduction of 14 percent. Net loss from continuing operations in the 2007 third quarter was $2.9 million or $0.04 loss per share as compared to $3.1 million or $0.05 loss per share in the comparable 2006 period. Net loss, including discontinued operations, for the third quarter of 2007 was $2.8 million, or a net loss per share of $0.04, as compared to a net loss of $4.0 million or net loss per share of $0.06 in the third quarter 2006.

Commenting further, Andrews said, "Another significant milestone in the quarter was the first revenue achieved from services related to our novel marker strategy. Along with continued growth from existing cancer diagnostic services, we believe our novel marker program can provide us with additional high-growth revenue streams, which are the foundation of our new business model. While revenue in novel markers is modest now, we are currently in various stages of development with key programs in each of the areas of cancer in which we have franchises. We expe
'/>"/>

SOURCE Clarient, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Kylie generates awareness about mammography
2. Health Insurance Scheme Generates Conflicting Opinions
3. Stem Cell Therapy Regenerates Heart Muscle In Heart Attack Patients
4. Body generates Antibiotic against Urinary Tract Infection
5. Soy Protein Study Generates New Findings
6. Dairy Farmers, Cheesed Off Over Revenue Loss from WIC Program
7. Use of Cellular Phones associated with Increased risk of Brain Tumors
8. Mortality increased in Sporting enthusiasts!
9. Tattoos may significantly increase risk of hepatitis C infection
10. Increase in sugar...decrease in brain function!!!
11. Increase in tobacco deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)... Dr. Stephen Cohen Hired As New CEO, ATLANTA,...r Group,(GMCG) announced today that MELCO Investme...ment fund, has signed on as a key partner with a,s...the investment, GMCG has,also appointed Dr. Stephe...,surgeons, as its new CEO., (Photo: http://www.n...
(Date:7/23/2008)...d and Medicare Rules Highlighted; a Focus on Preve...tions, LANSING, Mich., July 23 /PRNewswire/ -- Th...&PSI), a national leader in clinical risk manageme... care institutions and,providers, today announced ... conference., The conference will take place Sept...
(Date:7/23/2008)... Michigan Takes Top Honors as the #1 Healthiest Ci...PRNewswire-USNewswire/ -- AARP The Magazine, the,d...largest-circulation,magazine with more than 34 mil...st cities to live and retire in with Ann Arbor, MI...go, ND taking the top five rankings.,Featured in t...
(Date:7/23/2008)...a., July 23 /PRNewswire-USNewswire/ -- The HealthC...m ) today announced that Dr. Fran Cogen,MD, direc...am at Children,s,National Medical Center, will pro...om, a site offering connections to a community of ...priate consultation by a dietician, social,worker,...
Breaking Medicine News(10 mins):Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 2Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 3Health News:The Risk Management and Patient Safety Institute Announces 2008/2009 Annual Risk Management Conference, Dates 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 3Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 4Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 5Health News:Children's National Medical Center Program Director to Provide Expertise to DiabeTeens.com, The HealthCentral Network's Teen Diabetes Site 2
...nza can be slowed by immunizing chickens. The dise...vaccine has been developed for protecting chickens...ndrea Gambotto of the University of Pittsburgh. ... advantageous way of stopping the spread of the di...
...ter of the Indian state of Kerala underwent a surg...ng his hip after a fall. // He was visiting Switze..., with the object of promoting his state as an inv...overing well after the surgery, even though he wil...
...ission (NHRC) has called for a report with regard ...dneys and has issued the Chief Secretary and the D...unjab with a notice. // As many as 300 laborers i...eys since the year 2001, and about 25 of them are ...
...e US in 2005 from the fatal arrhythmias through de...As many as 1,70,000 people in North America receiv...o found this to be uncomfortable, unnecessary, and...loped recently to find out which of the patients a...
Other Medicine News:
(Date:7/22/2008)...r Therapeutics Development Initiative bring MJFF,s...t deadline January 20,2009, NEW YORK, July 22 /P...,speed delivery of transformative treatments and a...Foundation for Parkinson,s Research has awarded,$2...ch teams. The awards,were granted under MJFF,s The...
(Date:7/22/2008)...T Study Confirms Tyrima Exhibits Excellent Drug-Li... - Results Support Initiation of Phase II Clinical.../- CeNeRx BioPharma,Inc., a clinical...vative,treatments for diseases of the central nerv...ead candidate Tyrima(TM) into Phase II trials for ...
(Date:7/22/2008)...O, Calif., July 22 /- Hyperion,Therap... patient enrollment,in its Phase 1/2 clinical tria... scavenging effects of HPN-100 (formally called GT...patients with urea cycle disorders,(UCD). The comp...th quarter,of this year., (Logo: http://www.news...
(Date:7/22/2008)...novative Laser Lipolysis Technology in the Europea..., Mass., July 22 /- Cynosur...manufacturer of a broad array of,light-based aesth...CE Mark,for Smartlipo MPX(TM), the company,s high-...liquefy fat and tighten skin through collagen,remo...
Breaking Medicine Technology:Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3Living longer with obesity means heavier burden for hospitals 7969 1Living longer with obesity means heavier burden for hospitals 7969 2Living longer with obesity means heavier burden for hospitals 7969 3Mutated Suppressor Gene Leads to a Type of Breast Cancer 7967 1Mutated Suppressor Gene Leads to a Type of Breast Cancer 7967 2Mutated Suppressor Gene Leads to a Type of Breast Cancer 7967 3New drug candidate knocks out resistant form of chronic myeloid leukemia 7964 1New drug candidate knocks out resistant form of chronic myeloid leukemia 7964 2Decreasing access to cigarettes for youth in the Minnesota Adolescent Community Cohort Study 7961 1
...lif.--(BUSINESS WIRE)--May 15, 2007 - Synthetic Bl...ed positive data from,a statistical analysis of it...h traumatic brain injury. In line with preliminary...ical results,confirmed that the primary endpoint o...red with baseline was met. Data also show a,decrea...
...th ISIS 301012 produced at least 45% additional,re...,maximally-tolerated lipid-lowering therapies, CAR... -- Isis,Pharmaceuticals, Inc. announced updated r...ISIS 301012 in patients with homozygous,familial h...ch were,presented in March at the of Cardiology An...
Other Medicine Technology:Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor
Centuries of German Craftsmanship have produced the finest surgical instrumentation in the world. Ocutek® now makes them available to you! Only holders of the coveted Meisterbrief certificate, wh
Centuries of German Craftsmanship have produced the finest surgical instrumentation in the world. Ocutek now makes them available to you! Only holders of the coveted Meisterbrief certificate, which r
Centuries of German Craftsmanship have produced the finest surgical instrumentation in the world. Ocutek now makes them available to you! Only holders of the coveted Meisterbrief certificate, which r
Medicine Products: